Bristol Stock- S.Korea says Novavax, Sputnik V COVID-19 vaccines submitted for regulatory approval
SEOUL, April 29 (Reuters) – South Korea’s drug safety ministry said on Thursday that Russia’s Sputnik V coronavirus vaccine and a shot developed by Novavax NVAX.O have been submitted for preliminary regulatory approval.
(Reporting by Hyonhee Shin; editing by John Stonestreet)
(([email protected]; 822 3704 5658;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.